12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

  • Windtree Therapeutics WINT stock increased by 28.8% to $0.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.5 million.
  • Sorrento Therapeutics SRNE shares moved upwards by 24.8% to $0.48. The market value of their outstanding shares is at $263.5 million.
  • MediciNova MNOV stock increased by 16.52% to $2.68. The market value of their outstanding shares is at $131.4 million.
  • Cognition Therapeutics CGTX shares moved upwards by 16.2% to $1.9. The company's market cap stands at $55.0 million.
  • Immix Biopharma IMMX stock rose 15.45% to $2.39. The company's market cap stands at $33.2 million.
  • Spruce Biosciences SPRB shares increased by 12.5% to $2.7. The company's market cap stands at $63.6 million.

Losers

  • Monopar Therapeutics MNPR stock decreased by 17.0% to $2.78 during Wednesday's pre-market session. The company's market cap stands at $35.9 million.
  • Quoin Pharmaceuticals QNRX shares decreased by 15.97% to $1.0. The market value of their outstanding shares is at $4.8 million.
  • Chemomab Therapeutics CMMB shares decreased by 14.85% to $1.95. The market value of their outstanding shares is at $22.4 million.
  • Aclarion ACON shares fell 11.71% to $0.68. The market value of their outstanding shares is at $5.3 million.
  • eFFECTOR Therapeutics EFTR stock declined by 10.01% to $0.45. The company's market cap stands at $18.9 million.
  • Charles River CRL shares fell 10.0% to $219.25. The market value of their outstanding shares is at $11.1 billion. The company's, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!